All articles tagged with #modified risk
The FDA cleared 20 Philip Morris–owned Zyn nicotine pouches to carry a modified-risk claim, saying switching from cigarettes lowers the risk of several diseases; this gives the company a major marketing advantage as cigarette sales decline, though the FDA stresses no tobacco product is safe; the products come in 3 mg and 6 mg strengths across multiple flavors.
The FDA has allowed 20 Zyn nicotine-pouch products to market claims that using Zyn instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis, based on the totality of evidence. Regulators say the decision helps provide adults who smoke with science-based information about relative harms. The move is a win for PMI and Swedish Match, though critics warn about cardiovascular effects and note many users aren’t former smokers, highlighting ongoing debate about harm reduction and political associations around the product.